Ikaria Announces FDA 510(k) Clearance for Compatibility of its INOMAX Drug-Delivery System

AARC Corporate Partner, Ikaria , recently announced that the FDA has granted 510(k) clearance for compatibility of its INOMAX drug-delivery systems with six additional respiratory care devices.

The FDA's clearance of compatibility with these respiratory care devices makes Ikaria's INOMAX drug-delivery systems fully compatible with most invasive mechanical ventilation methods and non-invasive respiratory strategies used in neonatal intensive care units (NICUs), including continuous positive airway pressure (CPAP) and nasal cannulae.

Ikaria rejoined the AARC Corporate Partner Program in 2011. The AARC's Corproate Partner Program is comprised of best-in-class organizations interested in supporting the goals and work of the Association.

---